Qiming Venture Partners Portfolio Founders Named to Wealth China 40 Under 40 Business Elite Lists
The 40 Under 40 Business Elite list spotlights China's most influential young leaders of the moment, while the 40 Under 40 Most Promising Business Elite list selects the most promising innovators across industries. These are the young people driving change in Chinese business — and shaping the world.
Recently, Wealth (Chinese edition) released its 40 Under 40 Business Elite list and 40 Under 40 Most Promising Business Elite list for China. The former spotlights the country's most influential young leaders today, while the latter identifies the most promising innovators across industries — the young people driving change in Chinese business and shaping the world.
Qiming Venture Partners portfolio companies are well represented: JK, founder and CEO of Insta360 (688775.SH); Lixue Xia, co-founder and CEO of Infinigence AI; He Wang, founder and CTO of Galaxy Universal; and Xue Li, founder of Jieti Medical, were named to the 40 Under 40 Business Elite list. Xiang Li, founder and CEO of Shize Biotech; and Yang Wu, co-founder and CEO of moodytiger, were named to the 40 Under 40 Most Promising Business Elite list.
JK, Founder and CEO of Insta360 Lixue Xia, Co-founder and CEO of Infinigence AI He Wang, Founder and CTO of Galaxy Universal Xue Li, Founder of Jieti Medical Named to the 40 Under 40 Business Elite list
Xiang Li, Founder and CEO of Shize Biotech Yang Wu, Co-founder and CEO of moodytiger Named to the 40 Under 40 Most Promising Business Elite list
The editorial team at Wealth (Chinese edition) noted that China's young innovators excel at finding opportunity amid uncertainty and capturing inspiration in change. For these entrepreneurs, their shared mission extends beyond technological innovation to bridging divides, understanding differences, and leading the future. They are using AI to push the boundaries between machines and humans, with humanoid robots now participating in normal human labor; using AI to accelerate innovative drug experiments by hundreds of times; and using AI to make "flexible manufacturing" — long an ideal in industry — a reality.
Consistent with last year, an increasing number of entrepreneurs on the 40 Under 40 Business Elite list are active in the following sectors: artificial intelligence, healthcare, green technology, new consumer brands, and intelligent manufacturing.
Source | Wealth China
Past Coverage
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. More than 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), SinoCellTech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.